Boston Scientific, USA: Medical Devices, Products and Healthcare Technologies
Introduction
Boston Scientific Corporation is a major American medical technology company specializing in minimally invasive medical devices and technologies. The company develops products used by physicians to diagnose and treat cardiovascular, gastrointestinal, urological, neurological and other medical conditions.
Unlike diversified healthcare companies that manufacture medicines, nutrition products and diagnostic machines across many unrelated categories, Boston Scientific is particularly focused on medical devices and interventional therapies.
Its portfolio includes coronary stents, pacemakers, cardiac monitors, electrophysiology systems, left atrial appendage closure devices, endoscopy products, kidney-stone treatment technologies, prostate-treatment systems, neuromodulation devices and interventional oncology products.
Boston Scientific reported approximately $20.1 billion in 2025 net sales, with Cardiovascular representing about 66% and MedSurg about 34% of total sales.
What Does Boston Scientific Make?
Boston Scientific’s medical technology portfolio can broadly be divided into:
- Cardiac rhythm management devices
- Pacemakers
- Implantable cardioverter-defibrillators
- Cardiac resynchronization systems
- Cardiac monitoring devices
- Electrophysiology equipment
- Cardiac mapping and ablation technologies
- Coronary stents
- Peripheral vascular devices
- Structural and interventional heart technologies
- WATCHMAN left atrial appendage closure devices
- Endoscopy equipment
- Gastrointestinal stents and accessories
- Bronchoscopy products
- Urology devices
- Kidney-stone treatment equipment
- Flexible ureteroscopes
- Prostate treatment technologies
- Neuromodulation systems
- Spinal cord stimulators
- Deep brain stimulation systems
- Interventional oncology devices
- Embolization systems
- Cryoablation technologies
- Pelvic-health devices
The company’s current core business areas include Cardiac Rhythm Management, Electrophysiology, Endoscopy, Interventional Cardiology & Vascular Therapies, Neuromodulation, Urology, WATCHMAN, and Interventional Oncology & Embolization.
1. Cardiovascular Medical Devices
Cardiovascular technology is Boston Scientific’s largest business area.
The company develops minimally invasive devices for diseases involving the heart and vascular system.
These technologies can be used in:
- Coronary artery disease
- Heart rhythm disorders
- Heart failure
- Peripheral vascular disease
- Stroke-risk reduction
- Structural heart procedures
- Electrophysiology
- Vascular interventions
Boston Scientific’s 2025 annual report shows Cardiovascular as its largest reportable segment.
2. Pacemakers
Boston Scientific develops pacemakers for patients with certain abnormal or slow heart rhythms.
A pacemaker delivers electrical impulses when the heart’s natural rhythm is insufficient to maintain an appropriate heart rate.
Boston Scientific’s pacemaker portfolio includes systems such as the INGENIO family.
Depending on the system, pacemakers can be designed with features that help physicians manage different cardiac rhythm conditions.
3. Implantable Cardioverter-Defibrillators
Boston Scientific also makes implantable cardioverter-defibrillators (ICDs).
An ICD is an implanted cardiac device that can detect dangerous ventricular arrhythmias and deliver therapy when necessary.
These devices are used for selected patients at risk of life-threatening abnormal heart rhythms.
The company’s cardiac rhythm management portfolio covers technologies intended to monitor and treat irregular heart rhythms, heart failure and sudden cardiac arrest.
4. Cardiac Resynchronization Therapy
Boston Scientific also produces Cardiac Resynchronization Therapy (CRT) systems.
CRT devices are used in selected patients with heart failure and electrical conduction abnormalities.
Depending on the system, CRT may involve:
- CRT-P
- CRT-D
These devices are designed to coordinate the contractions of the heart’s chambers and can form part of comprehensive heart-failure treatment.
Boston Scientific lists both CRT-D and CRT-P systems within its current product portfolio.
5. Insertable Cardiac Monitors
Boston Scientific also develops small implantable monitoring devices.
The LUX-Dx Insertable Cardiac Monitor System is designed to continuously monitor cardiac activity for selected patients.
These systems can help physicians investigate intermittent or difficult-to-detect heart rhythm problems.
The company currently lists LUX-Dx among its featured cardiac products.
6. Electrophysiology
Electrophysiology (EP) is another major Boston Scientific business.
EP procedures examine the electrical activity of the heart and can be used to diagnose and treat abnormal rhythms.
Boston Scientific provides technologies such as:
- Mapping catheters
- Ablation catheters
- Electrophysiology systems
- Navigation technologies
- Diagnostic catheters
- Transseptal access devices
The company describes its electrophysiology business as a portfolio of technologies for diagnosing and treating heart rhythm disorders.
7. Pulsed Field Ablation
One of Boston Scientific’s important newer electrophysiology technologies is pulsed field ablation (PFA).
The company’s FARAPULSE PFA Platform uses pulsed electrical fields for cardiac ablation.
Ablation is performed to eliminate or isolate abnormal electrical tissue that contributes to certain heart rhythm disorders.
Boston Scientific currently highlights FARAPULSE among its featured healthcare-professional products.
The exact indications and availability of PFA systems depend on regulatory approvals in each market.
8. Coronary Stents
Boston Scientific develops coronary stents used during minimally invasive coronary interventions.
A stent is placed inside a narrowed artery to help maintain the vessel’s opening after treatment.
The company’s portfolio includes drug-eluting coronary stents.
One example is the SYNERGY family of everolimus-eluting coronary stents, which Boston Scientific lists among its cardiovascular technologies.
9. Interventional Cardiology
Boston Scientific provides a broad range of technologies for percutaneous coronary intervention (PCI).
These include:
- Coronary stents
- Guidewires
- Balloons
- Imaging systems
- Access devices
- Atherectomy technologies
- Other interventional tools
The company’s interventional cardiology business is designed around minimally invasive treatment of coronary and vascular disease.
10. Intravascular Imaging
Boston Scientific also develops technologies that allow physicians to examine blood vessels from inside the vascular system.
These technologies can provide information about:
- Vessel diameter
- Plaque
- Narrowing
- Stent placement
- Vessel structure
The company’s AVVIGO+ Multi-Modality Guidance System is one example of its current interventional cardiology portfolio.
11. Peripheral Vascular Devices
Not every vascular problem occurs in the coronary arteries.
Boston Scientific also develops products for peripheral vascular disease.
These technologies can be used in vessels involving areas such as:
- Legs
- Carotid arteries
- Renal arteries
- Other peripheral vascular regions
Products include drug-eluting stents and specialized balloon technologies.
Examples listed by Boston Scientific include the Eluvia Drug-Eluting Vascular Stent System and Ranger Paclitaxel-Coated PTA Balloon Catheter.
12. WATCHMAN Heart Device
One of Boston Scientific’s best-known cardiovascular technologies is WATCHMAN.
WATCHMAN is a left atrial appendage closure (LAAC) device.
It is designed for selected patients with non-valvular atrial fibrillation who may need an alternative approach to long-term stroke-risk management.
The device is implanted through a minimally invasive procedure and is designed to close the left atrial appendage.
Boston Scientific identifies WATCHMAN as one of its major core businesses and describes it as a device designed to reduce stroke risk in appropriate patients with non-valvular atrial fibrillation.
13. Endoscopy Products
Boston Scientific has a major Endoscopy business.
Its endoscopy products are designed for diagnosing and treating gastrointestinal and pancreaticobiliary conditions.
The portfolio includes:
- Endoscopic clips
- Stents
- Biopsy devices
- Single-use scopes
- Endoscopic suturing systems
- Drainage systems
- ERCP technologies
- Infection-prevention products
Boston Scientific’s current endoscopy portfolio also includes technologies for endoluminal procedures and certain obesity-treatment approaches.
14. Gastrointestinal Stents
Boston Scientific produces different types of gastrointestinal stents.
These can be used to help manage certain blockages or abnormal narrowing within the gastrointestinal and biliary systems.
Examples include:
- Biliary stents
- Enteral stents
- Drainage stents
- Other specialized GI stent systems
The company’s WallFlex Biliary Stent System and AXIOS Stent are examples from its current endoscopy portfolio.
15. AXIOS Stent System
The AXIOS Stent and Electrocautery-Enhanced Delivery System is designed for certain endoscopic drainage procedures.
It can be used by specialists in appropriate clinical situations involving fluid collections and related gastrointestinal or pancreatic conditions.
The AXIOS platform is part of Boston Scientific’s endoscopy portfolio.
16. Single-Use Endoscopy
Boston Scientific has expanded into disposable and single-use endoscopic technologies.
Examples include:
- LithoVue
- EXALT
- SpyGlass
- Other single-use scopes
The advantage of a single-use scope can include avoiding some of the processing and reprocessing requirements associated with reusable equipment.
Boston Scientific currently lists single-use endoscopes for multiple clinical applications.
17. Urology Products
Urology is another major Boston Scientific business.
The company develops technologies for:
- Kidney stones
- Benign prostatic hyperplasia (BPH)
- Prostate cancer
- Erectile dysfunction
- Urinary incontinence
- Overactive bladder
- Pelvic-floor disorders
Boston Scientific describes its urology business as providing minimally invasive solutions across these conditions.
18. Kidney Stone Treatment Devices
This is an especially important part of Boston Scientific’s urology portfolio.
The company produces equipment and accessories used during procedures for urinary stones.
These include:
- Ureteroscopes
- Stone baskets
- Guidewires
- Ureteral access sheaths
- Ureteral stents
- Balloons
- Lithotripsy systems
- Lasers
Boston Scientific’s current urology portfolio specifically includes kidney-stone management products.
19. LithoVue Flexible Ureteroscope
The LithoVue system is a single-use digital flexible ureteroscope.
It is designed to allow urologists to visualize and treat stones within the urinary tract.
The newer LithoVue Elite adds intrarenal pressure monitoring and other workflow features.
Boston Scientific currently describes LithoVue Elite as a system designed to access, visualize and treat urinary stones.
20. Laser Systems for Kidney Stones
Boston Scientific’s urology portfolio also includes laser technologies.
These can be used for procedures involving urinary stones.
Examples include:
- Lumenis Pulse Holmium Laser Systems
- MOSES Technology
- Thuvera Thulium Fiber Laser System
These technologies are intended to help physicians fragment or dust urinary stones during endoscopic procedures.
21. BPH Treatment
Boston Scientific also produces technologies for Benign Prostatic Hyperplasia (BPH).
BPH is enlargement of the prostate that can cause lower urinary tract symptoms.
Boston Scientific’s portfolio includes:
- GreenLight XPS Laser Therapy System
- Rezūm Water Vapor Therapy
- Other BPH-related technologies
Rezūm uses controlled water-vapor energy to target obstructive prostate tissue.
22. Erectile Dysfunction and Male Incontinence
Boston Scientific’s urology portfolio also includes implantable technologies for selected male-health conditions.
Examples include:
- AMS 700 Penile Implant
- AMS 800 Artificial Urinary Sphincter
- Male sling systems
These technologies are designed for selected patients with erectile dysfunction or urinary incontinence.
Boston Scientific lists these therapies within its urology portfolio.
23. Pelvic Health and Sacral Neuromodulation
Boston Scientific also offers technologies for pelvic-health conditions.
Its portfolio includes:
- Sacral neuromodulation
- Urinary incontinence technologies
- Overactive bladder therapies
- Fecal incontinence therapies
- Urethral bulking systems
- Pelvic-floor products
The Axonics Sacral Neuromodulation System is one of its current technologies and is designed for selected patients with conditions including overactive bladder, urinary urge incontinence, urinary retention and fecal incontinence.
24. Neuromodulation
Boston Scientific’s Neuromodulation business focuses on implantable technologies and therapies for chronic pain and neurological conditions.
Its portfolio includes:
- Spinal cord stimulation
- Deep brain stimulation
- Other neuromodulation technologies
The company describes neuromodulation as a core business focused on chronic pain and neurological conditions.
25. Spinal Cord Stimulators
Spinal cord stimulation (SCS) uses electrical stimulation to influence pain signaling.
Boston Scientific’s portfolio includes systems such as:
- WaveWriter Alpha
- Other spinal cord stimulation technologies
These systems are intended for selected patients with chronic pain after appropriate medical evaluation.
Boston Scientific currently lists WaveWriter Alpha among its featured medical products.
26. Deep Brain Stimulation
Boston Scientific also develops Deep Brain Stimulation (DBS) technologies.
DBS involves implanting electrodes in specific brain regions and delivering controlled electrical stimulation.
It can be used for selected neurological movement disorders.
Boston Scientific’s current portfolio includes Vercise DBS technologies, including newer lead systems designed to provide physicians with more options for individualized therapy.
27. Interventional Oncology
Cancer treatment is another growing area of Boston Scientific’s medical-device business.
Its Interventional Oncology and Embolization business includes technologies designed to support minimally invasive cancer procedures.
The portfolio includes:
- Embolization products
- Tumor ablation
- Cryoablation
- Radioembolization
- Biopsy technologies
- Other interventional oncology tools
Boston Scientific specifically identifies embolization, cryoablation and Y-90 technologies within this business.
28. Y-90 Radioembolization
Radioembolization is a minimally invasive approach used in certain liver-cancer treatment pathways.
Boston Scientific’s oncology portfolio includes Y-90 technologies.
The company has also highlighted TheraSphere glass microspheres as part of its radioembolization business.
Treatment suitability depends on cancer type, stage, anatomy and specialist evaluation.
29. Cryoablation
Boston Scientific also offers technologies used for cryoablation.
Cryoablation uses extreme cold to destroy targeted tissue.
In interventional oncology, this approach can be considered for selected tumors depending on their location and clinical circumstances.
It is one of the technologies included in Boston Scientific’s interventional oncology portfolio.
30. Bronchoscopy and Pulmonary Products
Boston Scientific’s product portfolio also includes technologies for pulmonary procedures.
Its healthcare-professional specialty catalog lists products for:
- Bronchoscopy
- Pulmonary procedures
- Biopsy
- Airway intervention
The company’s specialty product catalog includes devices such as the EXALT Model B Single-Use Bronchoscope and pulmonary biopsy technologies.
31. Gynecology and Pelvic Health
Boston Scientific also provides selected technologies used in gynecology and pelvic-health procedures.
Its medical specialty catalog includes:
- Gynecology products
- Pelvic health products
- Urethral bulking technologies
- Other minimally invasive systems
The company’s current specialty listing includes both gynecology and pelvic-health categories.
32. Gastrointestinal Surgery
The company also has products that support gastrointestinal surgical and endoluminal procedures.
These include:
- Endoscopic suturing
- Tissue closure
- Hemostatic clips
- Biopsy tools
- Stents
- Endoscopic accessories
Boston Scientific’s OverStitch platform is an example of its endoluminal surgical technology.
Boston Scientific Product Portfolio at a Glance
Medical Area Major Product Types Cardiac Rhythm Pacemakers, ICDs, CRT systems Electrophysiology Mapping, ablation, PFA Interventional Cardiology Coronary stents, balloons, vascular devices WATCHMAN Left atrial appendage closure Peripheral Vascular Drug-eluting stents, coated balloons Endoscopy Clips, scopes, stents, suturing systems Urology Ureteroscopes, lasers, stone devices BPH GreenLight, Rezūm Neuromodulation Spinal cord and brain stimulation Oncology Embolization, cryoablation, Y-90 Pulmonology Bronchoscopes, biopsy devices Pelvic Health Sacral neuromodulation, incontinence products
These categories reflect Boston Scientific’s current medical-specialty and core-business portfolio.
Boston Scientific’s 2025 Business Snapshot
Boston Scientific reported approximately $20.074 billion in net sales for 2025.
Its reported businesses included:
- Endoscopy — approximately $2.916 billion
- Urology — approximately $2.709 billion
- Neuromodulation — approximately $1.199 billion
- MedSurg total — approximately $6.824 billion
- Cardiovascular total — approximately $13.250 billion
Cardiovascular represented approximately 66% of total 2025 sales, while MedSurg represented approximately 34%.
In the fourth quarter of 2025, Boston Scientific reorganized its legacy Cardiology and Peripheral Interventions businesses into a combined Cardiovascular business within its reporting structure.
Boston Scientific and Minimally Invasive Treatment
One of Boston Scientific’s defining characteristics is its emphasis on less-invasive procedures.
Instead of relying only on traditional open surgery, many of its technologies are designed to be delivered through:
- Catheters
- Endoscopes
- Guidewires
- Small incisions
- Percutaneous access
- Implantable systems
This approach can allow physicians to reach specific areas of the body while reducing the need for larger surgical openings in appropriate procedures.
The actual benefits and risks depend on the specific device, procedure and patient’s condition.
Boston Scientific in India
Boston Scientific also operates in India and provides medical technologies to healthcare professionals.
Its products can be relevant to Indian specialties such as:
- Interventional cardiology
- Electrophysiology
- Urology
- Endoscopy
- Neuromodulation
- Interventional oncology
- Vascular medicine
Availability of individual products depends on Indian regulatory approvals, hospital procurement and the specific clinical indication.
Research and Innovation
Research and product development are central to Boston Scientific’s business model.
The company invests in new minimally invasive technologies across areas such as:
- Cardiovascular medicine
- Electrophysiology
- Endoscopy
- Urology
- Neuromodulation
- Oncology
- Peripheral vascular intervention
Recent developments have included newer electrophysiology technologies, neuromodulation products, urology technologies and oncology platforms.
Frequently Asked Questions
1. What is Boston Scientific?
Boston Scientific is a U.S.-based medical technology company that develops minimally invasive devices for cardiovascular, gastrointestinal, urological, neurological and other medical specialties.
2. What products does Boston Scientific make?
Its portfolio includes pacemakers, ICDs, CRT systems, coronary stents, electrophysiology devices, WATCHMAN, endoscopes, kidney-stone devices, prostate-treatment systems, spinal cord stimulators, DBS systems and cancer-intervention technologies.
3. Does Boston Scientific make pacemakers?
Yes. Pacemakers are part of its cardiac rhythm management portfolio.
4. Does Boston Scientific make heart stents?
Yes. The company produces coronary stents and other interventional cardiovascular devices.
5. What is WATCHMAN?
WATCHMAN is a left atrial appendage closure device intended for selected patients with non-valvular atrial fibrillation to reduce stroke risk.
6. Does Boston Scientific make kidney-stone equipment?
Yes. Its urology portfolio includes ureteroscopes, stone baskets, stents, access devices, lithotripsy systems and lasers.
7. What is LithoVue?
LithoVue is a single-use digital flexible ureteroscope used by urologists to visualize and treat urinary stones. The LithoVue Elite version adds features including intrarenal pressure monitoring.
8. Does Boston Scientific make cancer-treatment devices?
Yes. Its interventional oncology portfolio includes embolization, cryoablation and Y-90 radioembolization technologies.
9. Does Boston Scientific make spinal cord stimulators?
Yes. Boston Scientific produces spinal cord stimulation systems for selected chronic-pain patients.
10. Does Boston Scientific operate in India?
Yes. Boston Scientific has a presence in India, although specific device availability depends on regulatory approvals and local market conditions.
Conclusion
Boston Scientific, USA is one of the world’s major medical-device companies, with a particularly strong position in minimally invasive cardiovascular, endoscopic, urological, neurological and oncology procedures.
Its cardiovascular portfolio includes pacemakers, ICDs, CRT systems, coronary stents, electrophysiology technologies and the WATCHMAN left atrial appendage closure device. Its MedSurg portfolio extends into endoscopy, urology and neuromodulation.
For urologists, Boston Scientific offers technologies ranging from flexible ureteroscopes and kidney-stone lasers to BPH treatment systems and pelvic-health devices. For neurologists and pain specialists, its portfolio includes deep brain stimulation and spinal cord stimulation technologies. Its interventional oncology business adds embolization, cryoablation and Y-90 technologies for selected cancer-treatment procedures.
Overall, Boston Scientific’s core identity is built around less-invasive medical treatment technologies that allow physicians to diagnose, access and treat difficult conditions through specialized devices and procedural systems.
